MAPT and Alzheimer disease: The Lumipulse G phosphorylated tau protein at amino acid position 217 (pTau217)/amyloid beta protein fragment 1-42 (Aß1-42) plasma ratio is a recently FDA-cleared blood test designed to aid in the diagnosis of AD by detecting amyloid pathology in the brain.